HIPAA Compliance for Ketamine Infusion Records: A Clinic’s Guide
Ketamine infusion records can contain sensitive medical, mental health, and treatment information. A clinic’s privacy obligations depend on whether it is a HIPAA-covered entity, what information it maintains, and whether additional rules—such as 42 CFR Part 2—apply.
This guide explains how to protect protected health information (PHI), document infusion care, handle psychotherapy notes, respond to patient access requests, and build practical safeguards. It is general information, not legal advice; clinics should also consider applicable state law and professional requirements.
What HIPAA protections apply to ketamine infusion records?
HIPAA does not create a separate privacy category specifically for ketamine treatment. Instead, the Privacy Rule generally protects identifiable health information held or shared by covered entities and their business associates. A health care provider—including a clinic—is generally a covered entity if it conducts certain standard transactions electronically, such as electronic billing. See HHS guidance on covered entities.
When HIPAA applies, infusion records that identify a patient and relate to their health or care are PHI. The Privacy Rule governs how covered clinics may use and disclose PHI; the Security Rule requires reasonable and appropriate safeguards for electronic PHI. These protections apply whether the record concerns ketamine for a behavioral health condition, pain, or another clinical purpose. See HHS’s Summary of the HIPAA Privacy Rule and Summary of the HIPAA Security Rule.
The minimum necessary standard generally requires a covered clinic to make reasonable efforts to limit PHI used, disclosed, or requested to what is needed for the purpose. It does not apply to certain situations, including disclosures to or requests by a health care provider for treatment and disclosures to the patient. See HHS guidance on the minimum necessary requirement.
What information should infusion documentation include?
HIPAA does not prescribe a ketamine-specific documentation template. The following is a practical clinical documentation framework, not a claim that every item is expressly required by HIPAA. Clinics should adapt it to their clinicians’ judgment, applicable standards, and state requirements.
- Clinical context: The reason for treatment, relevant history, assessment, and treatment plan.
- Consent and planning: Treatment discussions, consent documentation, and relevant pre-infusion considerations.
- Infusion details: The medication administered, dose, route, timing, and the responsible clinician or staff.
- Monitoring and response: Clinically relevant observations, patient response, adverse events, and actions taken.
- Aftercare: Discharge instructions, follow-up plans, and communications relevant to ongoing care.
Keep documentation accurate, timely, and attributable to the person who entered it. Separate routine clinical records from psychotherapy notes when those notes meet HIPAA’s specific definition. Avoid recording sensitive details that are not relevant to care or another permitted purpose.
How should clinics handle psychotherapy notes?
HIPAA uses a narrow definition of psychotherapy notes: notes recorded by a mental health professional that document or analyze the contents of a private counseling session and are kept separate from the rest of the medical record. Routine progress notes, medication information, treatment plans, symptoms, and information maintained in the medical record generally do not become psychotherapy notes simply because they relate to mental health care. See HHS guidance on mental health information and psychotherapy notes.
In most cases, a covered entity must obtain the patient’s authorization before using or disclosing psychotherapy notes. That requirement can apply even when another health care provider requests the notes for treatment. HIPAA recognizes limited exceptions, so clinics should review the applicable rule rather than assume a general disclosure permission applies. See 45 CFR § 164.508.
For infusion care that includes psychotherapy, clinics should distinguish the ordinary medical record from separately maintained psychotherapy notes. Document clinically relevant information in the medical record, and restrict separately maintained notes to the appropriate staff and processes.
Ready to simplify HIPAA compliance?
Join thousands of organizations that trust Accountable to manage their compliance needs.
Get Started Free TodayWhen do substance use disorder confidentiality rules apply?
42 CFR Part 2 may apply to records of a federally assisted program that provides substance use disorder (SUD) diagnosis, treatment, or referral for treatment. Not every ketamine clinic is automatically a Part 2 program. A clinic’s use of ketamine, or treatment of a behavioral health condition, does not by itself answer whether Part 2 applies; assess the program’s services and federal-assistance status. See HHS’s overview of Part 2.
When Part 2 applies, the clinic should identify which records are Part 2 records and follow the rule’s requirements for their use and disclosure. The 2024 final rule has been in effect since April 16, 2024, and compliance was required by February 16, 2026. Under the updated rule, patients may provide a single consent for future treatment, payment, and health care operations disclosures; other restrictions, including protections concerning use in legal proceedings against a patient, remain important. See HHS information on Part 2 requirements and the 2024 final rule.
Clinics that may be subject to Part 2 should review their privacy notices, consent workflows, record-sharing procedures, and staff training. When a clinic is unsure whether Part 2 covers a program or particular records, it should seek qualified compliance or legal guidance before disclosing them.
How can patients access ketamine infusion records?
HIPAA generally gives patients the right to inspect or obtain copies of PHI in a designated record set—records maintained by or for a covered entity and used, in whole or in part, to make decisions about individuals. This commonly includes treatment and billing records, such as infusion documentation. Psychotherapy notes are generally excluded from this access right, but the patient may still access underlying clinical information in the designated record set. See HHS guidance on the right to access and designated record sets.
Give patients a clear way to submit an access request, verify identity appropriately, and track the response deadline. Under the rule currently in effect as of November 17, 2026, a covered entity generally must act within 30 calendar days, with one additional 30-day extension allowed when the clinic provides written notice explaining the delay and the expected response date. HHS issued a final rule on November 16, 2026, that will shorten the response period after its effective and compliance dates; clinics should monitor implementation. See HHS’s current access-response timeline and the 2026 HIPAA Privacy Rule final-rule summary.
Provide the information in the requested form and format when readily producible, or in another permitted format. Do not require patients to explain why they want their records. If charging a permitted fee, follow HIPAA’s limits on reasonable, cost-based fees. See HHS guidance on access requests and fees.
What safeguards help protect infusion records?
Build safeguards around the clinic’s actual risks, systems, and workflows. The HIPAA Security Rule calls for administrative, physical, and technical safeguards for electronic PHI, supported by an accurate and thorough risk analysis. HHS describes requirements including access controls, authentication, and audit controls that record and examine activity in systems containing or using electronic PHI. See HHS’s Summary of the HIPAA Security Rule.
- Limit access: Use role-based access so workforce members can view records appropriate to their duties, and remove access when it is no longer needed.
- Review activity: Maintain and examine audit controls to help identify inappropriate access or use.
- Secure records and devices: Protect paper charts, workstations, portable devices, and physical spaces from unauthorized access.
- Train the workforce: Teach staff how clinic policies apply to record access, disclosures, and patient requests.
- Manage vendors: Use appropriate written agreements when a business associate handles PHI on the clinic’s behalf.
- Prepare for incidents: Establish procedures to respond to suspected privacy or security incidents and assess whether breach notification is required.
Review safeguards periodically and when workflows, technology, or risks change. In short, clinics should document care clearly, distinguish ordinary clinical records from psychotherapy notes, determine whether Part 2 applies, respond to patient access requests on time, and protect records with risk-based safeguards.
FAQs
Are ketamine infusion records protected under HIPAA?
They are protected by HIPAA when the clinic is a covered entity or business associate and the records are PHI. Health care providers, including clinics, are generally HIPAA-covered when they conduct certain standard transactions electronically. Other privacy laws may also apply.
Can a clinic disclose psychotherapy notes without patient authorization?
Usually, a covered entity needs the patient’s authorization to use or disclose psychotherapy notes. HIPAA provides limited exceptions, so the clinic should confirm that a specific exception applies before disclosing them.
Do all ketamine clinics have to follow 42 CFR Part 2?
No. Part 2 generally applies to federally assisted programs that provide SUD diagnosis, treatment, or referral for treatment. A clinic’s use of ketamine alone does not determine whether it is a Part 2 program.
Can patients request copies of their infusion records?
Generally, yes. Patients can request access to PHI in the clinic’s designated record set, which commonly includes treatment and billing records. Psychotherapy notes are generally excluded from the HIPAA access right, and other limited exceptions may apply.
Table of Contents
- What HIPAA protections apply to ketamine infusion records?
- What information should infusion documentation include?
- How should clinics handle psychotherapy notes?
- When do substance use disorder confidentiality rules apply?
- How can patients access ketamine infusion records?
- What safeguards help protect infusion records?
- FAQs
Ready to simplify HIPAA compliance?
Join thousands of organizations that trust Accountable to manage their compliance needs.
Get Started Free Today